Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challenge.

[1]  Lisa Hartling,et al.  Risk of bias versus quality assessment of randomised controlled trials: cross sectional study , 2009, BMJ : British Medical Journal.

[2]  K. Dickersin,et al.  Metabias: A Challenge for Comparative Effectiveness Research , 2011, Annals of Internal Medicine.

[3]  A. Hrõbjartsson,et al.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.

[4]  Peter C Gøtzsche,et al.  Bmc Medical Research Methodology Open Access Recommendations by Cochrane Review Groups for Assessment of the Risk of Bias in Studies , 2022 .

[5]  J. Ioannidis,et al.  Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment , 2013, BMJ : British Medical Journal.

[6]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[7]  Isabelle Boutron,et al.  Single-Center Trials Show Larger Treatment Effects Than Multicenter Trials: Evidence From a Meta-epidemiologic Study , 2011, Annals of Internal Medicine.

[8]  G. Guyatt,et al.  Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. , 2010, JAMA.

[9]  Ethan M Balk,et al.  Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials , 2012, Annals of Internal Medicine.